Eli Lily cuts 2024 revenue guidance by $400M, shares sink 8%

The pharma major cut its revenue guidance for the year leading to an around 8% dip in its shares. The stock has gone down over 22% in the past six months. Eli Lily 2024 revenue guidance Eli …


Install CouponFollow Chrome Extension   CouponFollow Extension

8%
OFF

Eli Lily Cuts 2024 Revenue Guidance By $400M, Shares Sink 8%

2 weeks from now

The pharma major cut its revenue guidance for the year leading to an around 8% dip in its shares. The stock has gone down over 22% in the past six months. Eli Lily 2024 revenue guidance Eli …

msn.com

$45
OFF

Lilly Provides Update On 2024 Revenue Guidance, Announces 2025 …

2 weeks from now

Jan 14, 2025  · 2024 revenue is expected to be approximately $45.0 billion for the full year, $4.0 billion above the midpoint of first-time 2024 financial guidance. Q4 2024 revenue is expected …

lilly.com

3%
OFF

JP Morgan 2025: Eli Lilly Misses 2024 Revenue Estimate By $400m

2 weeks from now

Jan 15, 2025  · Eli Lilly has announced a $400m reduction in its 2024 revenue forecast, marking a 3% shortfall from its October 2024 guidance. The revised outlook, discussed at the JP Morgan …

yahoo.com

3%
OFF

Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion …

2 weeks from now

Jan 14, 2025  · The company’s expected 2024 revenue is $400 million, or about 3%, below the guidance range issued during. On Tuesday, Eli Lilly and Co (NYSE: LLY) announced that it …

yahoo.com

8%
OFF

Eli Lily Cuts 2024 Revenue Guidance By $400M, Shares Sink 8%

2 weeks from now

Jan 14, 2025  · Eli Lilly has reduced its 2024 revenue guidance by $400 million, leading to an 8% drop in its shares. The company now anticipates approximately $45 billion in revenue for 2024, …

longportapp.com

3%
OFF

Lilly Provides Update On 2024 Revenue Guidance, Announces 2025 …

2 weeks from now

Jan 14, 2025  · However, the company's expected 2024 revenue is $400 million, or about 3%, below the guidance range issued on October 30, 2024, as part of the Q3 2024 earnings call.

nasdaq.com

8%
OFF

Lilly Projects 2024 Revenue Miss As Zepbound, Mounjaro Disappoint

2 weeks from now

Jan 14, 2025  · The updated guidance, ... sent Eli Lilly’s shares cratering by as much as 8% Tuesday, ... Eli Lilly shaved off some stock Tuesday after reporting that it expected fourth …

biospace.com

45%
OFF

Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion …

2 weeks from now

Jan 14, 2025  · Eli Lilly expects fourth-quarter 2024 revenue of approximately $13.5 billion, representing a 45% year-over-year growth compared to the consensus of $13.97 billion. The …

sahmcapital.com

45%
OFF

Eli Lilly Issues Q4 2024 Revenue Guidance Below Consensus - MSN

2 weeks from now

The Q4 2024 revenue guidance represents a 45% growth year-over-year. LLY shares were trading -0.31% pre-market at $795.01. The 2024 revenue is estimated at ~$45.0B, roughly …

msn.com

32%
OFF

Lilly Provides Update On 2024 Revenue Guidance, Announces 2025 …

2 weeks from now

Eli Lilly and Company (NYSE: LLY) today announced that it expects 2024 full-year worldwide revenue to be approximately $45.0 billion, which represents growth of 32% compared to the …

yahoo.com

8%
OFF

Eli Lily Cuts 2024 Revenue Guidance By $400M, Shares Sink 8%

2 weeks from now

Eli Lilly saw its shares crash in early trade on Tuesday as the pharm major provided its revenue outlook for 2024 and 2025. The pharma major cut its revenue

onenewspage.com

32%
OFF

Eli Lilly Adjusts Outlook, CEO David Ricks Explains Revenue Shortfall

2 weeks from now

Jan 15, 2025  · Eli Lilly forecasts $45 billion in 2024 revenue, a 32% growth but $400 million below Q3 guidance. Mounjaro and Zepbound expected to contribute $3.5 billion and $1.9 billion, …

benzinga.com

8%
OFF

Eli Lily Cuts 2024 Revenue Guidance By $400M, Shares Sink 8%

2 weeks from now

Jan 14, 2025  · Eli Lilly saw its shares crash in early trade on Tuesday as the pharm major provided its revenue outlook for 2024 and 2025. The pharma major cut its revenue guidance …

kalkinemedia.com

32%
OFF

Eli Lilly And Company Revises Earnings Guidance For The Year 2024

2 weeks from now

Jan 14, 2025  · For the year, the company revised 2024 full-year worldwide revenue to be approximately $45.0 billion, which represents growth of 32% compared to the previous year. …

marketscreener.com

3%
OFF

Lilly Provides Update On 2024 Revenue Guidance, Announces 2025 …

2 weeks from now

Jan 14, 2025  · However, the company's expected 2024 revenue is $400 million, or about 3%, below the guidance range issued on October 30, 2024, as part of the Q3 2024 earnings call.

advfn.com

$45
OFF

Eli Lilly Adjusts Outlook, CEO David Ricks Explains Revenue Shortfall

2 weeks from now

Jan 15, 2025  · Just before the JP Morgan healthcare conference, Eli Lilly and Co (NYSE: LLY) announced that it expects 2024 full-year worldwide revenue to be approximately $45.0 billion, …

sahmcapital.com

32%
OFF

Eli Lilly Cuts Q4 Sales Forecast: ETFs To Buy On The Dip - Yahoo …

2 weeks from now

Eli Lilly also cut its revenue guidance for full-year 2024 to $45 billion from the previous expectation of $45.4-$46 billion. The new outlook still indicates 32% year-over-year growth in revenues.

yahoo.com

32%
OFF

Eli Lilly And Co (LLY) Q4 2024 Earnings Call Highlights: Record …

2 weeks from now

19 hours ago  · Eli Lilly and Co reported a 32% increase in full-year revenue for 2024, exceeding guidance by $4 billion. The company achieved a 45% revenue growth in Q4 2024, driven by …

yahoo.com

FAQs about Eli Lily cuts 2024 revenue guidance by $400M, shares sink 8% Coupon?

Why did Eli Lilly cut its 2024 revenue guidance?

Eli Lilly cut its 2024 revenue guidance, saying demand for its obesity and diabetes drugs had not met its lofty expectations. Eli Lilly expects about $3.5 billion in revenue for its diabetes treatment Mounjaro and $1.9 billion for its obesity drug Zepbound. ...

How much will Eli Lilly make in 2024?

Eli Lilly anticipates full-year worldwide revenue of approximately $45.0 billion in 2024, reflecting a 32% year-over-year growth but falling slightly below the consensus estimate of $45.49 billion. The company had earlier shared a revenue guidance of $45.4 billion to $46 billion earlier in October. ...

When will Eli Lily share Q4 2024 financial guidance?

The company currently plans to share its full Q4 2024 financial results, including with respect to other metrics included in its financial guidance, and 2025 financial guidance on February 6, 2025. The post Eli Lily cuts 2024 revenue guidance by $400M, shares sink 8% appeared first on Invezz ...

How did Eli Lilly perform in Q4 2024?

Eli Lilly and Co (NYSE:LLY) reported a 32% increase in full-year revenue for 2024, exceeding guidance by $4 billion. The company achieved a 45% revenue growth in Q4 2024, driven by strong performance of new products like Mounjaro and Zepbound. ...

Why did Eli Lilly stock drop?

Eli Lilly shares dropped after the drugmaker cut its 2024 revenue guidance, citing lower-than-expected demand for its obesity and diabetes drugs. ...

How much revenue does Eli Lilly expect in Q4?

For the fourth quarter, Eli Lilly expects $13.5 billion in revenue. The total includes about $3.5 billion for Mounjaro and $1.9 billion for Zepbound. Wall Street had expected fourth-quarter and full-year revenue of $13.94 billion and $45.49 billion, respectively, according to analysts surveyed by LSEG. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension